CFDE Data Portal | Search LINC01994

	Label	Description
	LINC01994 Gene (Entity type)	ENSG00000241098 - long intergenic non-protein coding RNA 1994
	GSE185200 GSE185202 L-13 Ali-BL 0 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE147815 GSE147817 LSD1 inhibition McCoy 2 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 9 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE195663 cisplatin 7 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE261563 CX-5461 9 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE240741 L-13 TIME 4 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE261563 CX-5461 7 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Brain 20-29 vs 30-39 Up Gene Set (Entity type)	A Gene Set from GTEx
	GSE162696 L-13 3 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS

LINC01994

ENSG00000241098 - long intergenic non-protein coding RNA 1994

GSE185200 GSE185202 L-13 Ali-BL 0 v 6 human up

A Gene Set from LINCS

GSE147815 GSE147817 LSD1 inhibition McCoy 2 v 3 human dn

A Gene Set from LINCS

GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 9 v 4 human dn

A Gene Set from LINCS

GSE195663 cisplatin 7 v 3 human dn

A Gene Set from LINCS

GSE261563 CX-5461 9 v 4 human up

A Gene Set from LINCS

GSE240741 L-13 TIME 4 v 3 human up

A Gene Set from LINCS

GSE261563 CX-5461 7 v 4 human up

A Gene Set from LINCS

GTEx Brain 20-29 vs 30-39 Up

A Gene Set from GTEx

GSE162696 L-13 3 v 1 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.